• Asbestos
• Class Actions
• Commercial Litigation
• Defective Products
• Drug Injury
• Personal Injury
• Securities Fraud
• Toxic Exposure
• Whistleblower Claims

Current Investigations

General

• False Credit Checks
• Herbalife Lawsuit
• Hidden Hotel Fees
• NFL Concussions

Drug Injury

• Actos
• Accutane
• Fosamax
• GranuFlo/NaturaLyte
• Gadolinium
  
• Ocella, Yasmin, Yaz
• Pradaxa
• Sleeping Pills
• SSRIs
  
• Topamax
• Tylenol
• Zithromax/Z-pack
  
• Zocor/Simvastatin
  

Medical Devices 

• Da Vinci Robot
• DePuy Hip Recall
• Mirena
• Stryker Recall
• Stryker Lawsuit
• Transvaginal Mesh
• Zimmer Hip Implant

Product Liability

• Aveeno Lawsuit
• Atlas Roofing Lawsuit
• Avon/Clarins Products
• AZEK Decking
• Chinese Drywall
• Chrysler Lock-Ups
• Demilec Insulation
  
• Electrolux Lawsuit
• Energy Drink Lawsuit
• Flushmate Systems
• Ford 5.4L Engine
• Ford & Mercury Transmissions
• Ford Mileage Claims
• GAF Decking
• Jeld-Wen Low E
• LP/ABTCO TrimBoard
• Norcold Lawsuit
• Pozzi and Jeld-Wen
• Remington Lawsuit
• TimberTech Decking
• Toyota Power Windows
• Trex Decking Lawsuit

Food 

• Arctic Zero
• Tropicana 

Pending Settlements

• Nutella Class Action Settlement

Search Seeger Weiss

Category : David Buchanan

Seeger Weiss Gets $18 Million Verdict For Two Former Accutane Users

On Friday, June 29, 2012, counsel for the plaintiff in yet another Hoffman La-Roche Accutane trial, led by Seeger Weiss partner David Buchanan and Troy Rafferty of Levin Papantonio, PA were able to secure an $18 million verdict. The plaintiffs in the drug injury lawsuit were Katie Rossitto and Riley Wilkinson, two former Accutane users who took the prescription acne medication in the 1990s and developed ulcerative colitis as a result. Ulcerative colitis, a debilitating, permanent gastrointestinal disease, is among the reported side effects of Accutane use. The New Jersey jury ultimately sided with Mr. Buchanan and the plaintiffs, finding that Hoffman La-Roche, the defendants and makers of Accutane, withheld its knowledge and conclusions about the risk of ulcerative colitis from doctors and patients. In response to the verdict, Mr. Buchanan, of Seeger Weiss LLP stated: “We’re extremely pleased for Katie and Riley. They’ve suffered greatly at the hands of Roche’s drug, and the jury’s verdict provides a measure of justice for each of them.” Learn more about the verdict here.